The Office of the Federal Register Inspections Desk posted today the pre-publication of the Medicare Program; Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2013 and Other Changes (PDF). This notice contains the Centers for Medicare & Medicaid Services’ (CMS) response to public comments received regarding their proposal to require consultant pharmacists to be independent from long-term care pharmacies, pharmaceutical manufacturers, and wholesalers. The section pertaining to consultant pharmacist independence begins on page 123, "Independence of LTC Consultant Pharmacists (Sec.483.60)".
ASCP is currently reviewing CMS’s response on this issue and other relevant sections of this notice. An analysis of the proposal will be available for the full membership on Thursday, April 5.
For more information, please visit the LTC Rule page.